Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing Network
Somerset, NJ, January 17, 2011 — Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, announced that it is enhancing a global network of Catalent sourcing specialists to supply comparator drugs directly from manufacturers, thereby reducing customer costs and ensuring timely initiation and reliability of product supply.
“Issues pertaining to supply chain management, such as reliability, pricing and security, often threaten to undermine the success of a clinical study,” said Frank Lis, Vice President and General Manager, Clinical Supply Services, Catalent Pharma Solutions. “In assembling this global network of comparator sourcing specialists, we aim to provide our clinical trials customers with the highest-quality supply, as well as competitive prices, fast procurement and a minimized risk of project delay and counterfeit products.”
The network’s sourcing specialists will cultivate a select group of leading innovators, manufacturers, and quality assurance professionals to access virtually any product in the world, and to identify the most cost-effective options for trial sponsors. Specialists will have access to Catalent’s comprehensive range of Clinical Supply Services, from manufacturing to packaging to distributing product directly to the clinical sites. This flexibility provides customers with improved support and control over the full sourcing process.
To learn more about Catalent’s direct comparator sourcing network, visit the Catalent booth at the upcoming Center for Business Intelligence’s Inaugural European Conference on Comparator Studies, January 19-20 at the Hilton London Paddington Hotel in London, UK, or visit http://www.catalent.com/pharma/clinical-supply-services.php .
Headquartered in Somerset, New Jersey, Catalent is a leading provider of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 29 facilities worldwide and in fiscal 2010 generated more than $1.7 billion of annual revenue. For more information, visit www.catalent.com.